SCHEMBL7944871

SCHEMBL7944871

Nc1ccnc2c1nc(-c1ncco1)c(=O)n2C1CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 5/20 0.38
MTOR P42345 5/20 0.38
CYP1A2 P05177 11/20 0.35
ALDH1A1 P00352 7/20 0.35
HPGD P15428 4/20 0.35
TSHR P16473 4/20 0.35
ALOX15 P16050 3/20 0.35
CYP2C19 P33261 3/20 0.35
MAPK1 P28482 4/20 0.34
CYP3A4 P08684 6/20 0.33
CYP2C9 P11712 5/20 0.33
HSD17B10 Q99714 4/20 0.33
CASP1 P29466 4/20 0.33
CASP7 P55210 4/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
GLA P06280 2/20 0.33
HIF1A Q16665 2/20 0.33
ADORA2A P29274 3/20 0.32
ADORA2B P29275 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7937482 0.81 CYP1A2 (0.46) AKT1MTORCYP1A2ALDH1A1HPGD
SCHEMBL7937497 0.80 AKT1 (0.41) AKT1MTORCYP1A2ALDH1A1HPGD
SCHEMBL7938046 0.80 AKT1 (0.37) AKT1MTORCYP1A2ALDH1A1HPGD
SCHEMBL7946948 0.79 CYP1A2 (0.40) AKT1MTORCYP1A2ALDH1A1HPGD
SCHEMBL7943737 0.79 CYP1A2 (0.57) AKT1MTORCYP1A2ALDH1A1HPGD
SCHEMBL7945874 0.78 ADORA2A (0.43) AKT1MTORALDH1A1TSHRADORA2A
SCHEMBL7937742 0.78 CYP1A2 (0.44) CYP1A2ALDH1A1HPGDTSHRALOX15
SCHEMBL7938293 0.77 CYP1A2 (0.48) AKT1MTORCYP1A2ALDH1A1HPGD
SCHEMBL7945511 0.77 AKT1 (0.36) AKT1MTORCYP1A2ALDH1A1HPGD
SCHEMBL7938413 0.76 CYP1A2 (0.44) AKT1MTORCYP1A2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010008775-A1 AMINOPYRIDOPYRAZINONE DERIVATIVES FOR TREATING NEURODEGENERATIVE DISEASES LIGAND PHARMACEUTICALS INC. (US) 2010-01-21 WO disclosed